Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of the Effect of Bepreve, a Topical Ocular Antihistamine, on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing

NCT01128556 is registered in ClinicalTrials.gov with North Texas Institute for Clinical Trials as lead sponsor.

NCT NCT01128556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01128556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of the Effect of Bepreve, a Topical Ocular Antihistamine, on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing
Lead sponsor
North Texas Institute for Clinical Trials
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2010
Completion date
June 30, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

histamine responsive allergy patients